Pfizer reports COVID-19 vaccine 95% effective as Phase 3 trial concludes
Pfizer and BioNTech have announced their large Phase 3 COVID-19 vaccine trial is complete. The trial has reportedly met all its primary endpoints and the vaccine is claimed to be 95 percent effective.Continue ReadingCategory: Health & Wellbeing, Li… Continue reading Pfizer reports COVID-19 vaccine 95% effective as Phase 3 trial concludes
